Thomas Lynch named one of 100 most influential CEOs in oncology

Dr. Thomas Lynch, professor (Hematology and Oncology) and president and director, Fred Hutch Cancer Center, has been named one of the 100 most influential CEOs in oncology in 2025 by OncoDaily.

This list recognizes 100 Chief Executive Officers whose leadership has had a measurable and lasting impact on the global oncology ecosystem.

During his tenure, Fred Hutch has strengthened its position as a global leader in basic, translational, and population-based cancer research, while deepening integration with clinical partners through the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium.

Under his leadership, the center has advanced large-scale, collaborative research initiatives spanning immunotherapy, cancer prevention, infectious disease–cancer intersections, and data-driven discovery.